MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: The potential for noninvasive diagnosis

Laura G. Remsen, Christopher I. McCormick, Simon Roman-Goldstein, Gajanan Nilaver, Ralph Weissleder, Alexei Bogdanov, Karl E. Hellström, Ingegerd Hellström, Robert A. Kroll, Edward Neuwelt

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

PURPOSE: To determine if tumor-specific monoclonal antibodies conjugated to superparamagnetic monocrystalline iron oxide nanoparticles can be used to yield specific diagnoses with the use of MR imaging. METHODS: Monoclonal antibodies conjugated to monocrystalline iron oxide nanoparticles were given to nude rats with intracranial tumors either by intravenous injection, intraarterial injection with osmotic blood-brain barrier disruption, or direct intratumoral inoculation. Either L6, a tumor-specific antibody, or P- 1.17, a control isotype-matched antibody, was used. Coronal T1-weighted, T2- weighted, and spoiled gradient-recalled acquisition in the steady state images were obtained before, 30 minutes after, 6 hours after, and 24 hours after injection. RESULTS: intravenous injection of greater than 2 mg of the tumor-specific antibody showed a specific pattern of enhancement of the tumors with the largest concentration of antibody in the area with the greatest density of tumor cells. The control antibody showed nonspecific changes. After intraarterial injection with barrier disruption to increase delivery globally or direct inoculation to increase delivery focally, no specific enhancement pattern was seen. CONCLUSION: Monoclonal antibodies conjugated with monocrystalline iron oxide particles may provide a method to obtain specific diagnoses with the use of MR imaging.

Original languageEnglish (US)
Pages (from-to)411-418
Number of pages8
JournalAmerican Journal of Neuroradiology
Volume17
Issue number3
StatePublished - 1996

Fingerprint

Monoclonal Antibodies
Neoplasm Antibodies
Carcinoma
Intra-Arterial Injections
Intravenous Injections
Antibodies
Neoplasms
Nude Rats
Blood-Brain Barrier
Cell Count
Injections
monocrystalline iron oxide nanoparticle

Keywords

  • Animal studies
  • Antigens and antibodies
  • Brain neoplasms, magnetic resonance
  • Carcinoma

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles : The potential for noninvasive diagnosis. / Remsen, Laura G.; McCormick, Christopher I.; Roman-Goldstein, Simon; Nilaver, Gajanan; Weissleder, Ralph; Bogdanov, Alexei; Hellström, Karl E.; Hellström, Ingegerd; Kroll, Robert A.; Neuwelt, Edward.

In: American Journal of Neuroradiology, Vol. 17, No. 3, 1996, p. 411-418.

Research output: Contribution to journalArticle

Remsen, LG, McCormick, CI, Roman-Goldstein, S, Nilaver, G, Weissleder, R, Bogdanov, A, Hellström, KE, Hellström, I, Kroll, RA & Neuwelt, E 1996, 'MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: The potential for noninvasive diagnosis', American Journal of Neuroradiology, vol. 17, no. 3, pp. 411-418.
Remsen, Laura G. ; McCormick, Christopher I. ; Roman-Goldstein, Simon ; Nilaver, Gajanan ; Weissleder, Ralph ; Bogdanov, Alexei ; Hellström, Karl E. ; Hellström, Ingegerd ; Kroll, Robert A. ; Neuwelt, Edward. / MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles : The potential for noninvasive diagnosis. In: American Journal of Neuroradiology. 1996 ; Vol. 17, No. 3. pp. 411-418.
@article{b3c34b00da4e4b7e89454942c8dab255,
title = "MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: The potential for noninvasive diagnosis",
abstract = "PURPOSE: To determine if tumor-specific monoclonal antibodies conjugated to superparamagnetic monocrystalline iron oxide nanoparticles can be used to yield specific diagnoses with the use of MR imaging. METHODS: Monoclonal antibodies conjugated to monocrystalline iron oxide nanoparticles were given to nude rats with intracranial tumors either by intravenous injection, intraarterial injection with osmotic blood-brain barrier disruption, or direct intratumoral inoculation. Either L6, a tumor-specific antibody, or P- 1.17, a control isotype-matched antibody, was used. Coronal T1-weighted, T2- weighted, and spoiled gradient-recalled acquisition in the steady state images were obtained before, 30 minutes after, 6 hours after, and 24 hours after injection. RESULTS: intravenous injection of greater than 2 mg of the tumor-specific antibody showed a specific pattern of enhancement of the tumors with the largest concentration of antibody in the area with the greatest density of tumor cells. The control antibody showed nonspecific changes. After intraarterial injection with barrier disruption to increase delivery globally or direct inoculation to increase delivery focally, no specific enhancement pattern was seen. CONCLUSION: Monoclonal antibodies conjugated with monocrystalline iron oxide particles may provide a method to obtain specific diagnoses with the use of MR imaging.",
keywords = "Animal studies, Antigens and antibodies, Brain neoplasms, magnetic resonance, Carcinoma",
author = "Remsen, {Laura G.} and McCormick, {Christopher I.} and Simon Roman-Goldstein and Gajanan Nilaver and Ralph Weissleder and Alexei Bogdanov and Hellstr{\"o}m, {Karl E.} and Ingegerd Hellstr{\"o}m and Kroll, {Robert A.} and Edward Neuwelt",
year = "1996",
language = "English (US)",
volume = "17",
pages = "411--418",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "3",

}

TY - JOUR

T1 - MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles

T2 - The potential for noninvasive diagnosis

AU - Remsen, Laura G.

AU - McCormick, Christopher I.

AU - Roman-Goldstein, Simon

AU - Nilaver, Gajanan

AU - Weissleder, Ralph

AU - Bogdanov, Alexei

AU - Hellström, Karl E.

AU - Hellström, Ingegerd

AU - Kroll, Robert A.

AU - Neuwelt, Edward

PY - 1996

Y1 - 1996

N2 - PURPOSE: To determine if tumor-specific monoclonal antibodies conjugated to superparamagnetic monocrystalline iron oxide nanoparticles can be used to yield specific diagnoses with the use of MR imaging. METHODS: Monoclonal antibodies conjugated to monocrystalline iron oxide nanoparticles were given to nude rats with intracranial tumors either by intravenous injection, intraarterial injection with osmotic blood-brain barrier disruption, or direct intratumoral inoculation. Either L6, a tumor-specific antibody, or P- 1.17, a control isotype-matched antibody, was used. Coronal T1-weighted, T2- weighted, and spoiled gradient-recalled acquisition in the steady state images were obtained before, 30 minutes after, 6 hours after, and 24 hours after injection. RESULTS: intravenous injection of greater than 2 mg of the tumor-specific antibody showed a specific pattern of enhancement of the tumors with the largest concentration of antibody in the area with the greatest density of tumor cells. The control antibody showed nonspecific changes. After intraarterial injection with barrier disruption to increase delivery globally or direct inoculation to increase delivery focally, no specific enhancement pattern was seen. CONCLUSION: Monoclonal antibodies conjugated with monocrystalline iron oxide particles may provide a method to obtain specific diagnoses with the use of MR imaging.

AB - PURPOSE: To determine if tumor-specific monoclonal antibodies conjugated to superparamagnetic monocrystalline iron oxide nanoparticles can be used to yield specific diagnoses with the use of MR imaging. METHODS: Monoclonal antibodies conjugated to monocrystalline iron oxide nanoparticles were given to nude rats with intracranial tumors either by intravenous injection, intraarterial injection with osmotic blood-brain barrier disruption, or direct intratumoral inoculation. Either L6, a tumor-specific antibody, or P- 1.17, a control isotype-matched antibody, was used. Coronal T1-weighted, T2- weighted, and spoiled gradient-recalled acquisition in the steady state images were obtained before, 30 minutes after, 6 hours after, and 24 hours after injection. RESULTS: intravenous injection of greater than 2 mg of the tumor-specific antibody showed a specific pattern of enhancement of the tumors with the largest concentration of antibody in the area with the greatest density of tumor cells. The control antibody showed nonspecific changes. After intraarterial injection with barrier disruption to increase delivery globally or direct inoculation to increase delivery focally, no specific enhancement pattern was seen. CONCLUSION: Monoclonal antibodies conjugated with monocrystalline iron oxide particles may provide a method to obtain specific diagnoses with the use of MR imaging.

KW - Animal studies

KW - Antigens and antibodies

KW - Brain neoplasms, magnetic resonance

KW - Carcinoma

UR - http://www.scopus.com/inward/record.url?scp=9244257373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9244257373&partnerID=8YFLogxK

M3 - Article

C2 - 8881233

AN - SCOPUS:9244257373

VL - 17

SP - 411

EP - 418

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 3

ER -